ProDGNE is a collaborative effort combining patient experience, complementary, and synergist expertise in glycobiology, biochemistry, medicinal chemistry, clinical pharmacology, -omics, biomarker discovery, pharmaceutical technology and clinical expertise to develop proof of principle of novel attractive compounds to treat GNE Myopathy (GNEM) and bring lead compounds one step closer to patients.


 

loading